TJ6-28023-40528
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 352 / AL
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-21
Registered in v-safe
-
2021-03-21
Dose 1 — Pfizer-BioNTech
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-04-04
-
2021-04-11
Dose 2 — Pfizer-BioNTech
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-13
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Eye pain, Sinus pain — Feeling: GoodFree text: Sinus pain behind R eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-17
- 2021-04-19
- 2021-04-26
-
2021-05-02
Survey response — day 21, dose 2MedDRA: Nausea — Feeling: GoodFree text: NauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-11
- 2021-05-18
- 2021-05-24
- 2021-07-13
-
2021-10-10
Survey response — 6 months, dose 2MedDRA: Menstruation irregular — Feeling: GoodFree text: Irregular cyclesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-17
Survey response — 12 months, dose 2MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Tested positive for Covid January 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-04-17
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-21 | Pfizer-BioNTech | |
| 2 | 2021-04-11 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Sinus pain behind R eye
Release 8 — day 21, dose 2
Symptoms: Nausea
Release 10 — 6 months, dose 2
Symptoms: Irregular cycles
Release 11 — 12 months, dose 2
Symptoms: Tested positive for Covid January 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Menstruation irregular | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
| SRO | Sinus pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release